ACTIVE

Barré

Export PDF

Financial year 2024 · Closed on 31/12/2024

Net result604,3 k €-0,8 %over 1 year
Gross margin2,4 M €-24,3 %over 1 year
Equity1,8 M €+49,5 %over 1 year
Workforce20,9 ETP

Identity

Source · BCE/KBO

Barré is a Public limited company incorporated in 1992. Its main activity is: Forging, pressing, stamping and roll-forming of metal; powder metallurgy. Its registered office is in Wavre. It employs on average 20,9 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0448.409.224
Incorporation
16/10/1992
Legal form
Public limited company
Registered office
Avenue Zénobe Gramme 38
1300 Wavre · WallonieSee on map
Contributed capital
62 500,00 €
Latest accounts
31/12/2024
Average workforce
20,9 ETP
Joint committees (4)
  • 111
  • 14901
  • 209
  • 218
Contacts
1 public detail availableLog in to view
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 21 filings

Trend over 18 financial years

20242024202320222021
Income statement
Gross margin2,4 M €3,1 M €2,9 M €2,4 M €1,9 M €
EBITDA995,6 k €1,2 M €1,1 M €985,1 k €666 k €
Operating result843,4 k €877,2 k €1,1 M €720,6 k €528,1 k €
Net result604,3 k €609 k €885 k €528,6 k €357,6 k €
Balance sheet
Equity1,8 M €1,2 M €2,1 M €2,7 M €2,5 M €
Total assets4,8 M €4,2 M €4,8 M €5,6 M €4,9 M €
Cash1 M €1,2 M €1,1 M €675,9 k €301,4 k €
Debts2,2 M €2,1 M €1,7 M €2,4 M €2 M €
Other
Workforce20,9 ETP0,0 ETP27,0 ETP19,0 ETP16,1 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 5 M€ and 10 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2024

2 active · 21 ended

Active mandates

Berthe Garcia Garza

Director · since 05 mai 2023

Active
BioScientific Group

Director · since 12 décembre 2019 · 0739.510.875

Represented by Javier MARTINEZ

Active

Ended mandates

Bertha Garcia Garza

Director · since 05 mai 2023

Ended
ARVEST GROUP

Director · since 20 décembre 2019 · 0838.550.746

Represented by Yves Warnant

Ended
ARVEST GROUP

Director · since 20 décembre 2019 · 0838.550.746

Represented by Yves WARNANT

Ended
BioScientific Group

Director · since 20 décembre 2019 · 0739.510.875

Represented by Javier Martinez

Ended

Other companies at this address

Avenue Zénobe Gramme 38 1300 Wavre
CompanyCBE no.
BioScientific Group● Active
0739.510.875

Full financial information

Source · NBB
202420242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/04/202401/04/202301/04/202201/04/202101/04/202001/01/2019
Closing of the financial year31/12/202431/03/202431/03/202331/03/202231/03/202131/03/2020
Length of the financial year9 months12 months12 months12 months12 months15 months
Filing date30/09/202516/09/202404/01/202405/10/202227/09/202122/09/2020
General meeting02/05/202512/09/202412/12/202326/09/202221/09/202108/09/2020
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 21 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202402/05/202530/09/2025FrenchPDF
Abridged model31/03/202412/09/202416/09/2024FrenchPDF
Abridged model31/03/202312/12/202304/01/2024FrenchPDF
Abridged model31/03/202226/09/202205/10/2022FrenchPDF
Abridged model31/03/202121/09/202127/09/2021FrenchPDF
Abridged model31/03/202008/09/202022/09/2020FrenchPDF
Abridged model31/12/201831/05/201913/06/2019FrenchPDF
Abridged modelCorrection31/12/201725/05/201811/10/2018FrenchPDF
Abridged model31/12/201725/05/201821/06/2018FrenchPDF
Abridged model31/12/201626/05/201701/06/2017FrenchPDF
Abridged model31/12/201527/05/201602/06/2016FrenchPDF
Abridged model31/12/201429/05/201503/06/2015FrenchPDF
Abridged model31/12/201330/06/201430/07/2014FrenchPDF
Abridged model31/12/201220/07/201319/08/2013FrenchPDF
Abridged model31/12/201130/06/201223/07/2012FrenchPDF
Abridged modelCorrection31/12/201010/07/201120/12/2011FrenchPDF
Abridged model31/12/201010/07/201110/08/2011FrenchPDF
Abridged model31/12/200930/06/201030/07/2010FrenchPDF
Abridged model31/12/200830/06/200911/08/2009FrenchPDF
Abridged model31/12/200726/06/200830/07/2008FrenchPDF
Abridged model31/12/200628/06/200727/07/2007FrenchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 5 M€ and 10 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2024

2 active · 21 ended

Active mandates

Berthe Garcia Garza

Director · since 05 mai 2023

Active
BioScientific Group

Director · since 12 décembre 2019 · 0739.510.875

Represented by Javier MARTINEZ

Active

Ended mandates

Bertha Garcia Garza

Director · since 05 mai 2023

Ended
ARVEST GROUP

Director · since 20 décembre 2019 · 0838.550.746

Represented by Yves Warnant

Ended
ARVEST GROUP

Director · since 20 décembre 2019 · 0838.550.746

Represented by Yves WARNANT

Ended
BioScientific Group

Director · since 20 décembre 2019 · 0739.510.875

Represented by Javier Martinez

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Other16/01/2025
    ASSEMBLEE GENERALE - ANNEE COMPTABLE
    PDF
  • Mandates23/02/2024
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates24/05/2023
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates06/01/2023
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates29/01/2020
    DENOMINATION - DEMISSIONS, NOMINATIONS - ASSEMBLEE GENERALE - ANNEE COMPTABLE
    PDF
  • Mandates16/01/2020
    DEMISSIONS, NOMINATIONS
    PDF
  • Capital / shares14/01/2020
    CAPITAL, ACTIONS
    PDF
  • Other28/06/2018
    OBJET
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2024
    Annual accounts 2024604,3 k €↓
  2. 2024
    Annual accounts 2024609 k €↓
  3. 2023
    Annual accounts 2023885 k €↑
  4. 2022
    Annual accounts 2022528,6 k €↑
  5. 2021
    Annual accounts 2021357,6 k €↑
  6. 2018
    Annual accounts 2018238 k €↑
  7. 2017
    Annual accounts 2017141,8 k €↓
  8. 2016
    Annual accounts 2016178,7 k €↓
  9. 2015
    Annual accounts 2015672,1 k €↑
  10. 2014
    Annual accounts 2014365,2 k €↓
  11. 2013
    Annual accounts 2013437,7 k €↓
  12. 2012
    Annual accounts 2012600,2 k €↓
  13. 2011
    Annual accounts 2011644,9 k €↑
  14. 2010
    Annual accounts 2010352,5 k €↑
  15. 2009
    Annual accounts 2009185,8 k €↓
  16. 2008
    Annual accounts 2008435,8 k €↑
  17. 2007
    Annual accounts 2007229,9 k €↑
  18. 2006
    Annual accounts 200684,1 k €
  19. 16/10/1992
    IncorporationPublic limited company